TransAct targets $55M-$56M 2026 net sales while refining adjusted EBITDA outlook to $1.5M-$1.75M
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.